News

• 2021.10.11 news
  The Cyclic Innovation for Clinical Empowerment (CiCLE) project of the Japan Agency for Medical Research and Development decided to continue supporting our clinical trial.
• 2021.10.04 news
  Our listing on the Tokyo Stock Exchange Mothers market and an article on the PAI-1 inhibitor RS5614 (for CML, COVID-19, etc.) were featured in The Chemical Daily.
• 2021.09.27 news
  Kahoku Shimpo featured our listing on the Tokyo Stock Exchange Mothers market as a Tohoku University venture.
• 2021.09.24 news
  Renascience announces the closing of its initial public offering on the Tokyo Stock Exchange Mothers market
• 2021.09.02 news
  Our efforts for the medical application of artificial intelligence (AI) (hemodialysis, respiratory diagnosis, etc.) were featured in Nikkei Biotechnology and Business
• 2021.08.18 news
  Notice Regarding Approval of Listing on the Tokyo Stock Exchange Mothers Market
• 2021.07.19 news
  Nikkei Sangyo Shimbun featured our work on AI project
• 2021.07.06 news
  Development of a swallowing function evaluation system using artificial intelligence was featured in the Chemical Daily.
• 2021.06.25 news
  Collaboration agreement with Nipro Corporation on chronic dialysis system support was featured in the morning edition of Nihon Keizai Shimbun
• 2021.06.25 news
  Collaboration Agreement with Nipro Corporation for the Development of Chronic Dialysis Support System.